DC101 Suppresses Tumor Growth with the Inhibition of Cell–Cell Interactions Between AFP-Positive Human HCC Cells and VEGFR2-Positive Mouse Vascular ECs in Human HCC Xenograft Models. This evidence concerns the gene KDR and hepatocellular carcinoma.